RNase-resistant virus-like particles containing long chimeric RNA sequences produced by two-plasmid coexpression system

Journal of Clinical Microbiology

Volumn 46, Issue 5, 2008, Pages 1734-1740

  Wei, Yuxiang ^a,b   Yang, Changmei ^a,b   Wei, Baojun ^a,b   Huang, Jie ^a,b   Wang, Lunan ^b   Meng, Shuang ^b   Zhang, Rui ^b   Li, Jinming ^a,b,c  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

^c National Center for Clinical Laboratory   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; ENZYME; MATURASE; RIBONUCLEASE; RNA;

ARTICLE; AVIAN INFLUENZA VIRUS MATRIX GENE; CONTROLLED STUDY; DILUTION; ESCHERICHIA COLI; GENE; HEPATITIS C VIRUS; INFLUENZA VIRUS A H5N1; MS2 VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS LIKE AGENT;

ESCHERICHIA COLI; HEPACIVIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; LEVIVIRUS; MACROMOLECULAR SUBSTANCES; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; RIBONUCLEASES; RNA, VIRAL; SARS VIRUS; VIRAL CORE PROTEINS; VIROSOMES;

AVIAN INFLUENZA VIRUS; ESCHERICHIA COLI; HEPATITIS C VIRUS; RNA VIRUSES; SARS CORONAVIRUS;

EID: 43249102953     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02248-07     Document Type: Article

References (29)

1. Argetsinger, J., and G. Gussin. 1966. Intact ribonucleic acid from defective particles of bacteriophage R17. J. Mol. Biol. 21:421-424.
2. Beld, M., R. Minnaar, J. Weel, C. Sol, M. Damen, H. van der Avoort, P. Wertheim-van Dillen, A. van Breda, and R. Boom. 2004. Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control. J. Clin. Microbiol. 42: 3059-3064.
3. Bressler, A. M., and F. S. Nolte. 2004. Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus. J. Clin. Microbiol. 42:987-991.
4. Das, A., E. Spackman, D. Senne, J. Pedersen, and D. L. Suarez. 2006. Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real-time reverse transcription-PCR with lyophilized reagents. J. Clin. Microbiol. 44:3065-3073.
5. Donia, D., M. Divizia, and A. Pana. 2005. Use of armored RNA as a standard to construct a calibration curve for real-time RT-PCR. J. Virol. Methods 126:157-163.
6. Eisler, D. L., A. McNabb, D. R. Jorgensen, and J. L. Isaac-Renton. 2004. Use of an internal positive control in a multiplex reverse transcription-PCR to detect West Nile virus RNA in mosquito pools. J. Clin. Microbiol. 42:841-843.
7. Heisenberg, M. 1966. Formation of defective bacteriophage particles by fr amber mutants. J. Mol. Biol. 17:136-144.
8. Hietala, S. K., and B. M. Crossley. 2006. Armored RNA as virus surrogate in a real-time reverse transcriptase PCR assay proficiency panel. J. Clin. Microbiol. 44:67-70.
9. Horn, W. T., M. A. Convery, N. J. Stonehouse, C. J. Adams, L. Liljas, S. E. Phillips, and P. G. Stockley. 2004. The crystal structure of a high affinity RNA stem-loop complexed with the bacteriophage MS2 capsid: further challenges in the modeling of ligand-RNA interactions. RNA 10:1776-1782.
10. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
11. Huang, Q., Y. Cheng, Q. Guo, and Q. Li. 2006. Preparation of a chimeric Armored RNA as a versatile calibrator for multiple virus assays. Clin. Chem. 52:1446-1448.
12. Konnick, E. Q., S. M. Williams, E. R. Ashwood, and D. R. Hillyard. 2005. Evaluation of the COBAS hepatitis C virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays. J. Clin. Microbiol. 43:2133-2140.
13. Lowary, P. T., and O. C. Uhlenbeck. 1987. An RNA mutation that increases the affinity of an RNA-protein interaction. Nucleic Acids Res. 15:10483-10493.
14. Oliver, A. R., S. F. Pereira, and D. A. Clark. 2007. Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR version 1.5 conventional PCR assay. J. Clin. Microbiol. 45:3616-3619.
15. Pasloske, B. L., C. R. Walkerpeach, R. D. Obermoeller, M. Winkler, and D. B. DuBois. 1998. Armored RNA technology for production of ribonucleasc-resistant viral RNA controls and standards. J. Clin. Microbiol. 36:3590-3594.
16. Pasloske, B. L., D. DuBois, D. Brown, and M. Winkler. April 2001. Ribonuclease-resistant RNA preparation and utilization. U.S. patent 6,214,982.
17. Pickett, G. G., and D. S. Peabody. 1993. Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein. Nucleic Acids Res. 21:4621-4626.
18. Romaniuk, P. J., P. Lowary, H. N. Wu, G. Stormo, and O. C. Uhlenbeck. 1987. RNA binding site of R17 coat protein. Biochemistry 26:1563-1568.
19. Rowsell, S., N. J. Stonehouse, M. A. Convery, C. J. Adams, A. D. Ellington, I. Hirao, D. S. Peabody, P. G. Stockley, and S. E. Phillips. 1998. Crystal structures of a series of RNA aptamers complexed to the same protein target. Nat. Struct. Biol. 5:970-975.
20. Saldanha, J., and A. Heath. 2003. Collaborative study to calibrate hepatitis C virus genotypes 2-6 against the HCV International Standard, 96/790 (genotype 1). Vox Sang 84:20-27.
21. Saldanha, J., A. Heath, C. Aberham, J. Albrecht, G. Gentili, M. Gessner, and G. Pisani. 2005. World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays. Vox Sang 88:202-204.
22. Scheuermann, R. H., and H. Echols. 1984. A separate editing exonuclease for DNA replication: the epsilon subunit of Escherichia coli DNA polymerase III holoenzyme. Proc. Natl. Acad. Sci. USA 81:7747-7751.
23. Shiba, T., and Y. Suzuki. 1981. Localization of A protein in the RNA-A protein complex of RNA phage MS2. Biochim. Biophys. Acta 654:249-255.
24. Stockley, P. G., N. J. Stonehouse, C. Walton, D. A. Walters, G. Medina, J. M. Macedo, H. R. Hill, S. T. Goodman, S. J. Talbot, and H. K. Tewary. 1993. Molecular mechanism of RNA-phage morphogenesis. Biochem. Soc. Trans. 21:627-633.
25. Stockley, P. G., N. J. Stonehouse, and K. Valegard. 1994. Molecular mechanism of RNA phage morphogenesis. Int. J. Biochem. 26:1249-1260.
26. Talbot, S. J., S. Goodman, S. R. Bates, C. W. Fishwick, and P. G. Stockley. 1990. Use of synthetic oligoribonucleotides to probe RNA-protein interactions in the MS2 translational operator complex. Nucleic Acids Res. 18: 3521-3528.
27. Valegard, K., J. B. Murray, N. J. Stonehouse, S. van den Worm, P. G. Stockley, and L. Liljas. 1997. The three-dimensional structures of two complexes between recombinant MS2 capsids and RNA operator fragments reveal sequence-specific protein-RNA interactions. J. Mol. Biol. 270:724-738.
28. WalkerPeach, C. R., M. Winkler, D. B. DuBois, and B. L. Pasloske. 1999. Ribonuclease-resistant RNA controls (armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus. Clin. Chcm. 45:2079-2085.
29. Witherell, G. W., J. M. Gott, and O. C. Uhlenbeck. 1991. Specific interaction between RNA phage coat proteins and RNA. Prog. Nucleic Acid Res. Mol. Biol. 40:185-220.